STOCK TITAN

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Fennec Pharmaceuticals (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, has announced its participation in two upcoming investor conferences. The company will be presenting at the H.C. Wainwright Global Investment Conference on September 11, 2024, from 12:00 p.m. to 12:30 p.m. ET in New York City. Additionally, Fennec will participate in a fireside chat at the Cantor Fitzgerald Global Healthcare Conference on September 19, 2024, from 8:35 a.m. to 9:05 a.m. ET, also in New York City.

The management team will be available for one-on-one investor meetings at both conferences. Investors can find additional information about these events on the company's website in the investor relations section.

Fennec Pharmaceuticals (NASDAQ:FENC; TSX: FRX), una società farmaceutica specializzata in fase commerciale, ha annunciato la sua partecipazione a due prossime conferenze per investitori. L'azienda presenterà al H.C. Wainwright Global Investment Conference il 11 settembre 2024, dalle 12:00 alle 12:30 ET a New York. Inoltre, Fennec parteciperà a una discussione informale al Cantor Fitzgerald Global Healthcare Conference il 19 settembre 2024, dalle 8:35 alle 9:05 ET, sempre a New York.

Il team dirigenziale sarà disponibile per incontri individuali con gli investitori in entrambe le conferenze. Gli investitori possono trovare ulteriori informazioni su questi eventi nella sezione delle relazioni con gli investitori del sito web dell'azienda.

Fennec Pharmaceuticals (NASDAQ:FENC; TSX: FRX), una compañía farmacéutica especializada en etapa comercial, ha anunciado su participación en dos próximas conferencias para inversores. La empresa presentará en la H.C. Wainwright Global Investment Conference el 11 de septiembre de 2024, de 12:00 p.m. a 12:30 p.m. ET en la ciudad de Nueva York. Además, Fennec participará en una charla informal en la Cantor Fitzgerald Global Healthcare Conference el 19 de septiembre de 2024, de 8:35 a.m. a 9:05 a.m. ET, también en la ciudad de Nueva York.

El equipo de gestión estará disponible para reuniones individuales con inversores en ambas conferencias. Los inversores pueden encontrar información adicional sobre estos eventos en la sección de relaciones con inversores del sitio web de la compañía.

Fennec Pharmaceuticals (NASDAQ:FENC; TSX: FRX), 상업 단계의 전문 제약 회사가 두 개의 다가오는 투자자 회의에 참여할 것이라고 발표했습니다. 이 회사는 2024년 9월 11일 오후 12:00부터 12:30까지 뉴욕시에서 열리는 H.C. Wainwright Global Investment Conference에서 발표할 예정입니다. 또한, Fennec는 2024년 9월 19일 오전 8:35부터 9:05까지, 역시 뉴욕에서 열리는 Cantor Fitzgerald Global Healthcare Conference에서 파이어사이드 채팅에 참여할 예정입니다.

경영진 팀은 두 회의에서 개별 투자자 회의를 위해 참석할 것입니다. 투자자들은 회사 웹사이트의 투자자 관계 섹션에서 이러한 이벤트에 대한 추가 정보를 찾을 수 있습니다.

Fennec Pharmaceuticals (NASDAQ:FENC; TSX: FRX), une société pharmaceutique spécialisée en phase commerciale, a annoncé sa participation à deux conférences pour investisseurs à venir. L'entreprise présentera lors de la H.C. Wainwright Global Investment Conference le 11 septembre 2024, de 12h00 à 12h30 ET à New York. De plus, Fennec participera à un entretien informel lors de la Cantor Fitzgerald Global Healthcare Conference le 19 septembre 2024, de 8h35 à 9h05 ET, également à New York.

L'équipe de direction sera disponible pour des réunions individuelles avec les investisseurs lors des deux conférences. Les investisseurs peuvent trouver des informations supplémentaires sur ces événements dans la section des relations avec les investisseurs du site Web de l'entreprise.

Fennec Pharmaceuticals (NASDAQ:FENC; TSX: FRX), ein spezialisiertes Pharmaunternehmen in der kommerziellen Phase, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen bekannt gegeben. Das Unternehmen wird am 11. September 2024 von 12:00 bis 12:30 Uhr ET in New York City auf der H.C. Wainwright Global Investment Conference präsentieren. Darüber hinaus wird Fennec am 19. September 2024 von 8:35 bis 9:05 Uhr ET ebenfalls in New York City an einem Fireside-Chat auf der Cantor Fitzgerald Global Healthcare Conference teilnehmen.

Das Management-Team steht auf beiden Konferenzen für persönliche Investorenmeetings zur Verfügung. Investoren finden weitere Informationen zu diesen Veranstaltungen im Bereich Investor Relations auf der Website des Unternehmens.

Positive
  • None.
Negative
  • None.

RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will be participating in upcoming investor conferences. The management team will also host one-on-one investor meetings at the conferences.

Conference Details:

Event: H.C. Wainwright Global Investment Conference
Date: September 11, 2024
Time: Company Presentation at 12:00 p.m. – 12:30 p.m. ET
Location: New York City, Lotte NY Palace Hotel, Holmes 1, 4th Floor

Event: Cantor Fitzgerald Global Healthcare Conference
Date: September 19, 2024
Time: Fireside Chat at 8:35 a.m. – 9:05 a.m. ET
Location: New York City, InterContinental Barclay Hotel, Track 3, Grand Ballroom 1

For additional information, please visit the investor relations section of the Company’s website at:
https://investors.fennecpharma.com/events-and-presentations/events.

About Fennec Pharmaceuticals
Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of PEDMARK® to reduce the risk of platinum-induced ototoxicity in pediatric patients. Further, PEDMARK received FDA approval in September 2022 and European Commission approval in June 2023 and U.K. approval in October 2023 under the brand name PEDMARQSI. PEDMARK has received Orphan Drug Exclusivity in the U.S. and PEDMARQSI has received Pediatric Use Marketing Authorization in Europe, which includes eight years plus two years of data and market protection. For more information, please visit www.fennecpharma.com.

For further information, please contact:

Investors:
Robert Andrade
Chief Financial Officer
Fennec Pharmaceuticals Inc.
+1 919-246-5299

Corporate & Media:
Lindsay Rocco 
Elixir Health Public Relations
+1 862-596-1304
lrocco@elixirhealthpr.com


FAQ

When is Fennec Pharmaceuticals (FENC) presenting at the H.C. Wainwright Global Investment Conference?

Fennec Pharmaceuticals (FENC) is presenting at the H.C. Wainwright Global Investment Conference on September 11, 2024, from 12:00 p.m. to 12:30 p.m. ET.

Where is the Cantor Fitzgerald Global Healthcare Conference being held for Fennec Pharmaceuticals (FENC)?

The Cantor Fitzgerald Global Healthcare Conference, where Fennec Pharmaceuticals (FENC) is participating, is being held at the InterContinental Barclay Hotel in New York City.

What type of session will Fennec Pharmaceuticals (FENC) have at the Cantor Fitzgerald Global Healthcare Conference?

Fennec Pharmaceuticals (FENC) will participate in a fireside chat at the Cantor Fitzgerald Global Healthcare Conference on September 19, 2024, from 8:35 a.m. to 9:05 a.m. ET.

Will Fennec Pharmaceuticals (FENC) management be available for one-on-one meetings at these conferences?

Yes, the management team of Fennec Pharmaceuticals (FENC) will be available for one-on-one investor meetings at both conferences.

Where can investors find more information about Fennec Pharmaceuticals' (FENC) conference participation?

Investors can find additional information about Fennec Pharmaceuticals' (FENC) conference participation in the investor relations section of the company's website at https://investors.fennecpharma.com/events-and-presentations/events.

Fennec Pharmaceuticals Inc.

NASDAQ:FENC

FENC Rankings

FENC Latest News

FENC Stock Data

166.51M
22.98M
16.22%
54.73%
6.8%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
RESEARCH TRIANGLE PARK